Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work With Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work With Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Glioma Metabolite Drives Neuronal Activity and Tumour Growth
September 2026
Glioma-derived GAA stimulates surrounding neurons and promotes tumour growth, revealing a potential treatment target.
Read more
20 Sep 2026
Glioma Metabolite Drives Neuronal Activity and Tumour Growth
Glioma-derived GAA stimulates surrounding neurons and promotes tumour growth, revealing a potential treatment target.
18 Sep 2026
Mobile Cancer Testing Defines Safer Outreach Pathways
A qualitative study developed an implementation-aware Target Product Profile for mobile cancer testing, identifying 42 attributes and key handover requirements.
16 Sep 2026
mRNA Nanoparticles Reprogramme Tumour Immune Environment
Targeted mRNA nanoparticles reprogrammed tumour-associated macrophages to support antitumour T-cell activity.
14 Sep 2026
Targeted Therapy Improves Outcomes in HER2 Lung Cancer: WCLC 2026
DESTINY-Lung04 data show trastuzumab deruxtecan improved progression-free survival and response rates in first-line HER2-mutant NSCLC.
14 Sep 2026
Amivantamab Extends Survival in Advanced NSCLC: WCLC 2026
Final PAPILLON data showed that first-line amivantamab chemotherapy extended median overall survival by more than 6 months in advanced EGFR Ex20ins NSCLC.
14 Sep 2026
Osimertinib Sustains Long-Term Survival Benefit in NSCLC: WCLC 2026
Eight-year ADAURA data showed sustained overall survival benefits with adjuvant osimertinib in patients with resected EGFR-mutated NSCLC.
14 Sep 2026
MRI Surveillance Improves Cognitive Outcomes in SCLC: WCLC 2026
An international phase III trial found that MRI surveillance alone improved cognitive failure free survival in patients with SCLC compared with PCI.
13 Sep 2026
Personalised Cancer Vaccine Shows Promise in Head and Neck Cancer
A personalised vaccine generated durable immune responses in patients treated for head and neck cancer.
Loading posts...
1
2
3
…
74
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View